YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Actonel
Injured by Actonel?
Actonel (generic: risedronate sodium), manufactured by Procter & Gamble, was granted FDA approval on March 27, 1998. Actonel is prescribed to treat postmenopausal osteoporosis. Actonel is a type of drug known as bisphosphonates, the same family of drugs as Fosamax, Aredia, and Zometa. Individuals using Actonel or other bisphosphonates should avoid tooth extractions and other major dental work while on the drugs.
A connection between Actonel (and other bisphosphonates) and a serious bone disease called Osteonecrosis of the Jaw (ONJ) was found. Osteonecrosis of the Jaw (ONJ) is also known as Dead Jaw. This finding was published in the Journal of Oral and Maxillofacial Surgeons, and it prompted the US Food and Drug Administration (FDA) and the manufacturer of Actonel to issue a warning to health care professionals on September 24, 2004.
Bisphosphonates are commonly used in tablet form to prevent and treat osteoporosis in post-menopausal women. Stronger forms of bisphosphonates are commonly used in the management of advanced cancers that have metastasized to the bone, where the disease often causes bone pain and possibly even fractures. Several cancers can involve or metastasize to the bone including lung cancer, breast cancer, prostate cancer, multiple myeloma, and others. When bisphosphonates are given in cancer chemotherapy, the drugs are given intravenously and usually for longer periods of time.
Osteonecrosis of the Jaw (ONJ) is a condition in which the bone tissue in the jaw fails to heal after minor trauma such as a tooth extraction, causing the bone to be exposed. The exposure can eventually lead to infection and fracture and may require long-term antibiotic therapy or surgery to remove the dying bone tissue. Experts say that prevention and early treatment of patients using bisphosphonates such as Actonel is extremely important in preserving the jawbone.
If you or a loved one took Actonel and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
BONE-DENSITY DRUGS CAN KILL JAWS
Jul 5, 2006 | Philadelphia Inquirer
Another Merck Drug Is Under Legal Attack
Jul 5, 2006 | Los Angeles Times
Bone-building drugs linked to bone-rotting side effect
Jun 13, 2006 | Star Ledger
Painful jaw decay tied to osteoporosis drugs
May 5, 2006 | www.cbc.ca
Quick Facts
Risedronate sodium
Date Approved
March 27, 1998
Manufacturer
Procter & Gamble
Status
Warning 9/24/04, still on the market
Approved Uses
Postmenopausal osteoporosis
Serious Side Effects
Osteonecrosis of the jaw
Hypersensitivity
Skin reactions
Rash Related Topics
Aredia
Fosamax
Zometa
Osteonecrosis of the Jaw (ONJ)
Defective Drugs
Diseases
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS
